CAMP4 Therapeutics Corporation (CAMP)
CAMP Stock Price Chart
Explore CAMP4 Therapeutics Corporation interactive price chart. Choose custom timeframes to analyze CAMP price movements and trends.
CAMP Company Profile
Discover essential business fundamentals and corporate details for CAMP4 Therapeutics Corporation (CAMP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
11 Oct 2024
Employees
55.00
Website
https://www.camp4tx.comCEO
Joshua Mandel-Brehm
Description
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
CAMP Financial Timeline
Browse a chronological timeline of CAMP4 Therapeutics Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.24, while revenue estimate is $1.62m.
Earnings released on 7 May 2026
EPS came in at -$0.32 falling short of the estimated -$0.21 by -52.38%, while revenue for the quarter reached $1.29m , beating expectations by +15.74%.
Earnings released on 5 Mar 2026
EPS came in at -$0.87 falling short of the estimated -$0.31 by -180.65%, while revenue for the quarter reached $300.00k , missing expectations by -36.87%.
Earnings released on 6 Nov 2025
EPS came in at -$0.55 falling short of the estimated -$0.47 by -17.02%, while revenue for the quarter reached $795.00k , beating expectations by +83.46%.
Earnings released on 14 Aug 2025
EPS came in at -$0.62 surpassing the estimated -$0.67 by +7.46%, while revenue for the quarter reached $1.50m , beating expectations by +161.81%.
Earnings released on 13 May 2025
EPS came in at -$0.62 surpassing the estimated -$0.70 by +11.43%, while revenue for the quarter reached $858.00k , beating expectations by +300.00%.
Earnings released on 27 Mar 2025
EPS came in at -$0.77 surpassing the estimated -$0.91 by +15.38%, while revenue for the quarter reached $652.00k , missing expectations by -3.55%.
Earnings released on 21 Nov 2024
EPS came in at -$24.19 falling short of the estimated -$1.07 by -2.15k%.
Earnings released on 8 Jul 2024
EPS came in at -$52.56 falling short of the estimated -$0.92 by -5.61k%.
Earnings released on 6 Jun 2024
EPS came in at -$1.03 surpassing the estimated -$2.04 by +49.51%.
Earnings released on 9 Jan 2024
EPS came in at -$3.91 falling short of the estimated -$2.30 by -70.00%, while revenue for the quarter reached $53.63m , missing expectations by -4.59%.
Earnings released on 5 Oct 2023
EPS came in at -$0.01 falling short of the estimated $0.03 by -133.33%, while revenue for the quarter reached $61.71m , missing expectations by -12.28%.
Earnings released on 10 Jul 2023
EPS came in at -$0.11 falling short of the estimated $0.92 by -111.96%, while revenue for the quarter reached $70.89m , missing expectations by -6.30%.
Earnings released on 27 Apr 2023
EPS came in at $1.38 surpassing the estimated $0.03 by +4.50k%, while revenue for the quarter reached $78.51m , missing expectations by -0.18%.
Earnings released on 20 Dec 2022
EPS came in at -$0.06 falling short of the estimated $0.05 by -230.43%, while revenue for the quarter reached $78.89m , beating expectations by +4.78%.
Earnings released on 22 Sept 2022
EPS came in at -$0.46 surpassing the estimated -$0.65 by +29.41%, while revenue for the quarter reached $72.83m , beating expectations by +5.13%.
Earnings released on 23 Jun 2022
EPS came in at -$2.30 falling short of the estimated -$0.73 by -215.79%, while revenue for the quarter reached $64.73m , missing expectations by -6.77%.
Earnings released on 28 Apr 2022
EPS came in at -$0.23 surpassing the estimated -$1.27 by +81.82%, while revenue for the quarter reached $68.38m , missing expectations by -0.09%.
Earnings released on 21 Dec 2021
EPS came in at -$1.84 falling short of the estimated -$0.23 by -700.00%, while revenue for the quarter reached $68.78m , beating expectations by +0.26%.
Earnings released on 23 Sept 2021
EPS came in at $1.84 surpassing the estimated $1.38 by +33.33%, while revenue for the quarter reached $79.01m , missing expectations by -55.56%.
CAMP Stock Performance
Access detailed CAMP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
